Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.50
+0.18 (3.38%)
At close: Apr 17, 2025, 4:00 PM
5.49
-0.01 (-0.18%)
After-hours: Apr 17, 2025, 7:27 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.21 billion as of April 17, 2025. Its market cap has increased by 5.38% in one year.
Market Cap
2.21B
Enterprise Value
1.73B
1-Year Change
5.38%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.21B, a decrease of -56.41%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 2.21B | -17.02% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |